MAP2K7 and non-small cell lung carcinoma: We therefore expected that PD‐L1 expression could be mediated by the E6 oncoprotein in NSCLC cells via the MEK/ERK and EGFR/ERK/NF‐κB signaling pathways, but this requires further investigation.